tirzepatide weight loss program telehealth Fridays | GLP-1 3 Best GLP-1 Telehealth 2026:
Description
Risks of compounded medications include potential dosing variability, contamination concerns, and less rigorous quality control compared to FDA-approved products
Because tirzepatide targets both GIP and GLP-1 pathways, it often yields greater weight loss than medications targeting GLP-1 alone
Plateaus lasting 2 to 6 weeks are normal and do not indicate dose inadequacy
It is also important to continue following a healthy diet and exercise plan while taking tirzepatide to help manage diabetes
Do not use a vial that has experienced significant temperature exposure during shipping
